PAX5, which has been recently identified within CLL subgroups as an essential super‐enhancer factor for CLL cell survival (Ott et al, 2018), was no top hit in our differential TF motif analysis of SEs in CLL vs. NBCs. This evidence concerns the gene TF and B-cell chronic lymphocytic leukemia.